Arrowhead Research Corp. (ARWR) Reports In-Line Q3 EPS, Provides Update on ARC-520
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/12/2026
- Wall Street ends higher as SpaceX's market debut dominates
- SpaceX prices historic IPO at $135/share in largest ever new listing
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- UBS cuts gold price forecasts on delayed Fed easing outlook
- Brent falls to lowest since March on expected peace deal
- NASDAQ adds five companies to NASDAQ-100 index in quarterly rebalance
- Adobe CFO Dan Durn to depart company in June 2026
- Oppenheimer Starts SpaceX (SPCX) at Outperform, PT $190, 'space infrastructure appears structurally advantaged'
- Pentagon reportedly locked down, hazmat teams responding
- Super Micro Computer establishes $1.25 billion stock sale agreement
Arrowhead Research (ARWR) Sees Early Upside
August 14, 2014 9:44 AM EDTArrowhead Research (NASDAQ: ARWR) seeing strong morning upside on solid volume. Shares are up 7%.
Deutsche Bank Maintains Buy Rating on Arrowhead Research (ARWR)
August 13, 2014 9:58 AM EDTDeutsche Bank maintained a Buy rating on Arrowhead Research (NASDAQ: ARWR) with a price target of $45. Comments follow its ARC-520 update.
Analyst Alethia Young said, "We feel more confident in ARC-520 and their platform technology after this interim update. Safety looks solid... More
Arrowhead Research (ARWR) Bullish Stance Reiterated at Jefferies as ARC-520 Shows Highly Encouraging Efficacy
August 13, 2014 6:52 AM EDTJefferies analyst Thomas Wei reiterated a Buy rating and $30 price target on Arrowhead Research (NASDAQ: ARWR) as ARC-520 shows highly encouraging efficacy.
Wei commented, "ARWR provided an update from its Phase 2a trial, in which patients receiving a single dose of ARC-520... More
